aXichem AB (OSTO:AXIC A) Other Stockholders Equity: kr-168.65 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:AXIC A aXichem AB OSTO:AXIC A
66 GF Score
Price kr3.14
GF Value kr3.59
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is aXichem AB Other Stockholders Equity?

aXichem AB OSTO:AXIC A +16.73% 66 Other Stockholders Equity is kr-168.65 Mil as of Mar. 2026. GuruFocus rates OSTO:AXIC A with a GF Score™ of 66/100 and a GF Value™ of kr3.59 (Modestly Undervalued). The stock has 1 warning sign investors should review.

aXichem AB's Other Stockholders Equity for the quarter that ended in Mar. 2026 was kr-168.65 Mil.

aXichem AB's quarterly Other Stockholders Equity declined from Sep. 2025 (kr-0.00 Mil) to Dec. 2025 (kr-148.15 Mil) and declined from Dec. 2025 (kr-148.15 Mil) to Mar. 2026 (kr-168.65 Mil).

aXichem AB's annual Other Stockholders Equity declined from Dec. 2023 (kr-109.51 Mil) to Dec. 2024 (kr-130.33 Mil) and declined from Dec. 2024 (kr-130.33 Mil) to Dec. 2025 (kr-148.15 Mil).

aXichem AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for aXichem AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aXichem AB Other Stockholders Equity Chart

aXichem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -77.12 -92.23 -109.51 -130.33 -148.15

aXichem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -148.15 -168.65
OSTO:AXIC A
66GF Score
aXichem AB OSTO:AXIC A
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr-168.65 Mil mean?
aXichem AB (OSTO:AXIC A) has a Other Stockholders Equity of kr-168.65 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on aXichem AB and its competitors.
Is aXichem AB's Other Stockholders Equity too high?
aXichem AB's current Other Stockholders Equity is kr-168.65 Mil. Overall, aXichem AB has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Other Stockholders Equity compare to LIN and SHW?
aXichem AB's Other Stockholders Equity of kr-168.65 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Chemicals company?
A good Other Stockholders Equity depends on the Chemicals industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on aXichem AB and its competitors. aXichem AB's current Other Stockholders Equity is kr-168.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
Based on GuruFocus' analysis, aXichem AB (OSTO:AXIC A) is currently considered Modestly Undervalued. The stock's GF Value™ is kr3.59, compared to a current price of kr3.14 — trading 12.5% below its estimated fair value. The current Other Stockholders Equity is kr-168.65 Mil. aXichem AB's overall GF Score™ is 66/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For aXichem AB (OSTO:AXIC A), the current Other Stockholders Equity is kr-168.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (OSTO:AXIC A) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of kr3.14 is trading 12.5% below its estimated GF Value™ of kr3.59. GuruFocus considers aXichem AB to be Modestly Undervalued.

Key valuation signals for OSTO:AXIC A:

  • Other Stockholders Equity: kr-168.65 Mil
  • GF Value™: kr3.59 vs. price of kr3.14 (12.5% below fair value)
  • GF Score™: 66/100 with 1 warning sign

No single metric tells the full story. See the OSTO:AXIC A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

aXichem AB Business Description

Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
66GF Score

Get the complete analysis for OSTO:AXIC A

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.14
Price
kr3.59
GF Value